Results 101 to 110 of about 3,869 (167)

Takotsubo cardiomyopathy following aeromonas hydrophila septic shock after traumatic injury: a case report. [PDF]

Front Cardiovasc Med
Zeng X, Chen Y, Du W, Zhou K.
europepmc   +1 more source

Novel drugs targeting genetic variants: current applications and future prospects in heart failure treatment. [PDF]

Front Mol Biosci
Li X, Bai S, Luo Y.
europepmc   +1 more source

Clinical outcomes of levosimendan administration in veno-arterial extracorporeal membrane oxygenation: a meta-analysis. [PDF]

BMJ Open
Zhao GM, Zhao GM, Zhang H, Chen W, Zhou JX, Li HL.   +5 more
europepmc   +1 more source

Impact of Pre-Heart Transplant Levosimendan Administration on Post-Transplant Vasoplegia and Primary Graft Dysfunction. [PDF]

Clin Transplant
Guzman-Bofarull J, Martín-Centellas A, Couto-Mallon D, Borràs R, Arenas-Loriente A, Rivas-Lasarte M, Segovia-Cubero J, Crespo-Leiro MG, García-Álvarez A, Farrero M.   +9 more
europepmc   +1 more source

Levosimendan in Decompensated Heart Failure with Reduced Ejection Fraction in Older Adults: A Systematic Review of Safety and Efficacy. [PDF]

Medicines (Basel)
Zavaleta-Monestel E, Mora-Jiménez J, Cruz-Mora K, Martinez-Vargas E, Díaz-Madriz JP, Arguedas-Chacón S, Fallas-Mora A, Wu-Chin C, Chaverrí-Fernandez JM.   +8 more
europepmc   +1 more source

Levosimendan versus dobutamine in septic cardiomyopathy: a randomized clinical trial on cardiac function and safety. [PDF]

Front Cardiovasc Med
Zhao F, Wei H, Lin L, Wang H, Zhang Z, Guo L.   +5 more
europepmc   +1 more source

Levosimendan to Facilitate Weaning From ECMO in Patients With Severe Cardiogenic Shock: The LEVOECMO Randomized Clinical Trial.

JAMA
Combes A, Saura O, Nesseler N, Lebbah S, Rozec B, Levy B, Fellahi JL, Beurton A, Meslin S, Gaudard P, Bouglé A, Vincentelli A, Sonneville R, Lebreton G, Lévy D, Ouattara A, Tubach F, LEVOECMO Trial Group and the International ECMO Network (ECMONet).   +17 more
europepmc   +1 more source

A hypoxia-on-a-chip platform for modeling ischemic arrhythmogenesis and evaluating the effects of levosimendan and OR-1896 on ischemic human iPSC-derived cardiomyocytes. [PDF]

Front Bioeng Biotechnol
Gaballah M, Walls K, Zakzook F, Kreutzer J, Levijoki J, Aalto-Setälä K.   +5 more
europepmc   +1 more source

Phenotype-Guided Outpatient Levosimendan as a Bridge-to-Transplant in Low-Output Advanced Heart Failure: A Single-Center Cohort. [PDF]

J Pers Med
Carvalheiro R, Santos AR, Teixeira AR, Reis JF, Gonçalves AV, Moreira RI, Pereira da Silva T, Gomes V, Coelho P, Ferreira RC.   +9 more
europepmc   +1 more source

"Intracoronary levosimendan in neonatal cardiac surgery: a retrospective study on hemodynamic effects and catecholamine-sparing outcomes". [PDF]

Front Cardiovasc Med
Ibraev T, Zhauarova G, Kerimkulov A, Rakhimova K, Sungkarbekov E.   +4 more
europepmc   +1 more source